Startseite Evaluating sample stability in the clinical laboratory with the help of linear and non-linear regression analysis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluating sample stability in the clinical laboratory with the help of linear and non-linear regression analysis

  • Joachim K.W. Pum EMAIL logo
Veröffentlicht/Copyright: 9. August 2019
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

As it is common practice for laboratories to store patient samples for a predefined period, allowing clinicians to request additional tests on previously collected samples, knowledge about sample stability is indispensable for the laboratorian. A common approach to estimating the maximum storage time is to use a discrete study design, measuring the analyte of interest at various time-points and then checking for significant differences with the help of a statistical test, such as Student’s t-test, Wilcoxon’s test or an analysis of variance (ANOVA) test. Because only discrete time intervals are considered, stability data can just be approximated. Alternatively, a continuous study design, as described by the Clinical and Laboratory Standards Institute (CLSI) for performing stability experiments for in vitro diagnostic reagents, can also be adopted by the clinical laboratory to evaluate the stability of biological samples. The major advantage of this approach is that it allows laboratories to define individual stability limits for different medical situations and offers more flexibility when choosing time-points for measurements. The intent of this paper is to demonstrate the evaluation of sample stability in the clinical laboratory with a continuous study design implemented with linear or non-linear regression analysis. Appropriate statistical modeling and acceptance criteria are presented, stability functions are described briefly, and checking the overall validity of the results is discussed.

  1. Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. DIN EN ISO 15189:2014. Medical laboratories – particular requirements for quality and competence. Geneva, Switzerland: International Organization for Standardization, 2014.Suche in Google Scholar

2. CAP – All Common Checklist, 08/21/2017 Edition, CAP Accreditation Program. Northfield, IL: College of American Pathologists, 2018.Suche in Google Scholar

3. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Immunogenicity testing of therapeutic protein products developing and validating assays for anti-drug antibody detection – Guidance for industry, 2019. https://www.fda.gov/media/119788/download. Accessed: 02 July 2019.Suche in Google Scholar

4. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Bioanalytical Method Validation – Guidance for Industry, 2018. https://www.fda.gov/media/70858/download. Accessed: 02 July 2019.Suche in Google Scholar

5. Briscoe C. Assessing stability in bioanalysis: reflections on the last 10 years. Bioanalysis 2019;11:579–82.10.4155/bio-2019-0043Suche in Google Scholar PubMed

6. Salih TM, El-Mahdi IM. The physical, chemical, and microbiological stability of chloramphenicol ophthalmic solution. Libyan Int Med Univ J 2018;0:1–7.10.4103/LIUJ.LIUJ_16_18Suche in Google Scholar

7. Boyanton BL, Blick KE. Stability studies of 24 analytes in human plasma and serum. Clin Chem 2002;48:2242–7.10.1093/clinchem/48.12.2242Suche in Google Scholar

8. Chua C, Tifigiu E, Boroujeni AM, Lin B, Laskar D, Shafique K, et al. Stability of values for the activities of critical enzymes assayed in serum frozen for prolonged time periods. Ann Clin Lab Sci 2018;48:618–26.Suche in Google Scholar

9. Parent X, Alenabi F, Brignon P, Souberbielle JC. Delayed measurement of PTH in patients with CKD: storage of the primary tube in the dialysis unit, which temperature, which kind of tube? Nephrol Ther 2009;5:34–40.10.1016/j.nephro.2008.04.006Suche in Google Scholar PubMed

10. Cuhadar S, Atay A, Koseoglu M, Dirican A, Hur A. Stability studies of common biochemical analytes in serum separator tubes with or without gel barrier subjected to various storage conditions. Bioch Med 2012;22:202–14.10.11613/BM.2012.023Suche in Google Scholar PubMed PubMed Central

11. ISO 5725-6:1994. Accuracy (trueness and precision) of measurement methods and results – Part 6: use in practice of accuracy values. Geneva, Switzerland: International Organization for Standardization, 1994.Suche in Google Scholar

12. Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012;45:464–9.10.1016/j.clinbiochem.2012.01.012Suche in Google Scholar PubMed

13. CLSI. Evaluation of stability of in vitro diagnostic reagents; approved guideline. CLSI document EP25-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2009.Suche in Google Scholar

14. European Medicines Agency (EMA). Note for guidance on evaluation of stability data (CPMP/ICH/420/02). London, UK: EMA, 2003.Suche in Google Scholar

15. Linsinger TP, van der Veen AM, Gawlik BM, Pauwels J, Lamberty A. Planning and combining of isochronous stability studies of CRMs. Accredit Qual Assur 2004;9:464–72.10.1007/s00769-004-0818-xSuche in Google Scholar

16. ISO Guide 35:2017 (E). Reference material – Guidance for characterization and assessment of homogeneity and stability, 4th ed. Geneva, Switzerland: International Organization for Standardization, 2017.Suche in Google Scholar

17. Lamberty A, Schimmel H, Pauwels J. The study of the stability of reference materials by isochronous measurements. Fresenius J Anal Chem 1998;360:356–61.10.1007/s002160050711Suche in Google Scholar

18. Zander J, Bruegel M, Kleinhempel A, Becker S, Petros S, Kortz L, et al. Effect of biobanking conditions on short-term stability of biomarkers in human serum and plasma. Clin Chem Lab Med 2014;52:629–39.10.1515/cclm-2013-0705Suche in Google Scholar PubMed

19. Plumhoff EA, Thrompson CK, Fisher PK, Bowie EJ, Nichols WL. Effects of specimen storage and handling on coagulation. Thromb Haemost 1993;69:866.Suche in Google Scholar

20. Woodhams B, Girardot O, Blanco MJ, Colesse G, Gourmelin Y. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinol 2001;12:229–36.10.1097/00001721-200106000-00002Suche in Google Scholar PubMed

21. Rouy D, Ernens I, Jeanty C, Wagner DR. Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation. Anal Biochem 2005;338:294–8.10.1016/j.ab.2004.10.052Suche in Google Scholar PubMed

22. Cuhadar S, Koseoglu M, Atay A, Dirican A. The effect of storage time and freeze-thaw cycles on the stability of serum samples. Bioch Med 2013;23:70–7.10.11613/BM.2013.009Suche in Google Scholar

23. Lee JE, Kim SY, Shin SY. Effect of repeated freezing and thawing on biomarker stability in plasma and serum samples. Osong Public Health Res Perspect 2015;6:357–62.10.1016/j.phrp.2015.11.005Suche in Google Scholar PubMed PubMed Central

24. European Medicines Agency – ICH Expert Working Group. ICH guideline M10 on bioanalytical method validation M10 – Draft version. London, UK: EMA, 2019.Suche in Google Scholar

25. De Vore K. Have more confidence in your stability data: two points to consider. J Pharm Biomed Anal 2006;42:293–8.10.1016/j.jpba.2005.10.038Suche in Google Scholar PubMed

26. Rioja RG, Espartosa DM, Segovia M, Ibarz M, Llopis MA, Bauça JM, et al. Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes. Clin Chem Lab Med 2018;56:1806–18.10.1515/cclm-2017-1189Suche in Google Scholar PubMed

27. Fraser C. Quality specifications. In: Biological variations: from principle to practice, 1st ed. Washington: AACC Press, 2001:29–67.Suche in Google Scholar

28. JCGM 100:2008. Evaluation of measurement data – guide to the expression of uncertainty in measurement. Sèvres, France: Joint Committee for Guides in Metrology, 2008.Suche in Google Scholar

29. Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G, Oosterhuis W, et al. Defining analytical performance specifications: consensus statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53:833–5.10.1515/cclm-2015-0067Suche in Google Scholar PubMed

30. Panton KK, Farup PG, Sagen E, Sirum UF, Asberg A. Vitamin B6 in plasma – sample stability and reference limits. Scan J Clin Lab Inv 2013;73:476–9.10.3109/00365513.2013.803234Suche in Google Scholar PubMed

31. Haeckel R, Wosniok W. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the art. Clin Chem Lab Med 2011;49:623–35.10.1515/CCLM.2011.116Suche in Google Scholar PubMed

32. Guder WG, Fiedler M, daFonseca WF, Schmitt Y, Töpfer G, Wisser H, et al. The quality of diagnostic samples, 4th completely revised edition. Oxford: BD Diagnostics, 2005.Suche in Google Scholar

33. German Medical Association. Guidelines of the German Medical Association for Quality Assurance of Medical Laboratory Tests. Ger Med J 2008;105:C301–13.Suche in Google Scholar

34. Macdonald R. Quality assessment of quantitative analytical results in laboratory medicine by root mean square of measurement deviation. J Lab Med 2000;30:111–7.10.1515/JLM.2006.018Suche in Google Scholar

35. Haeckel R, Wosniok W, Gurr E, Peil B. Permissible limits for uncertainty of measurement in laboratory medicine. Clin Chem Lab Med 2015;53:1161–71.10.1515/cclm-2014-0874Suche in Google Scholar PubMed

36. Haeckel R, Gurr E, Keller T. Permissible measurement uncertainty in the lower part of measurement intervals. J Lab Med 2016;40:271–6.10.1515/labmed-2016-0006Suche in Google Scholar

37. Oosterhuis WP, Bayat H, Armbruster D, Coskun A, Freeman KP, Kallner A, et al. The use of error and uncertainty methods in the medical laboratory. Clin Chem Lab Med 2018;56: 209–19.10.1515/cclm-2017-0341Suche in Google Scholar PubMed

38. Akbas N, Budd J, Klee G. Multiple calibrator measurements improve accuracy and stability estimates of automated immunoassays. Scand J Clin Lab Inv 2016;76:177–80.10.3109/00365513.2015.1126760Suche in Google Scholar

39. Bartels R. Re-interpreting R2, regression through the origin, and weighted least squares. https://www.researchgate.net/publication/283333191 Re-interpreting R-squared regression through the origin and weighted least squares. Accessed: 28 June, 2019.Suche in Google Scholar

40. Gujurati DN. Basic econometrics, 4th ed. New York: McGraw-Hill, 2003.Suche in Google Scholar

41. Bruggemann L, Quapp W, Wennrich R. Test for non-linearity concerning linear calibrated chemical measurements. Accred Qual Assur 2006;11:625–31.10.1007/s00769-006-0205-xSuche in Google Scholar

42. David G. Rhoads Associates. EP Evaluator ® Release 9.6, Manual: Chapter 28 – Stability.Suche in Google Scholar

43. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) – Guidance for industry. Q1A(R2) Stability testing of new drug substances and products. 2003. https://www.fda.gov/media/71707/download. Accessed: 02 July 2019.Suche in Google Scholar

44. Kwak S, Kim J. Central limit theorem: the cornerstone of modern statistics. Korean J Anesthesiol 2017;70: 144–56.10.4097/kjae.2017.70.2.144Suche in Google Scholar

45. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Erlbaum Associates, 1988.Suche in Google Scholar

46. de Winter JC. Using the Student’s t-test with extremely small sample sizes. Pract Assess Res Eval 2013;18:1–12.Suche in Google Scholar

47. Dzikiti L, Girdler-Brown B. Parametric hypothesis tests for the difference between two population means. Strengthen Health Syst 2017;2:40–6.Suche in Google Scholar

48. von Storch H. Taking serial correlation into account in tests of the mean. J Climate 1995;8:336–51.10.1175/1520-0442(1995)008<0336:TSCIAI>2.0.CO;2Suche in Google Scholar

49. Nahm FS. Nonparametric statistical tests for the continuous data: the basic concept and the practical use. Korean J Anesthesiol 2016;69:8–14.10.4097/kjae.2016.69.1.8Suche in Google Scholar

50. LABanalytics GmbH. Abacus 2.0 – Method-Validation, Quality-Control and Statistics Add-In for Microsoft Excel 2019. https://www.lab-analytics.com.Suche in Google Scholar

Received: 2019-06-13
Accepted: 2019-07-11
Published Online: 2019-08-09
Published in Print: 2020-01-28

©2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Towards a personalized assessment of vitamin D status
  4. Reviews
  5. Circulating tumor DNA and their added value in molecular oncology
  6. Telomere length determinants in childhood
  7. Opinion Papers
  8. Serum or plasma? An old question looking for new answers
  9. Evaluating sample stability in the clinical laboratory with the help of linear and non-linear regression analysis
  10. General Clinical Chemistry and Laboratory Medicine
  11. Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects
  12. How well do Croatian laboratories adhere to national recommendations for laboratory diagnostics of chronic kidney disease (CKD)?
  13. Underfilling of vacuum blood collection tubes leads to increased lactate dehydrogenase activity in serum and heparin plasma samples
  14. Calcium state estimation by total calcium: the evidence to end the never-ending story
  15. The use of faecal immunochemical testing in the decision-making process for the endoscopic investigation of iron deficiency anaemia
  16. Measurement uncertainty of β-lactam antibiotics results: estimation and clinical impact on therapeutic drug monitoring
  17. Practical approach to method verification in plasma and validation in cerebrospinal fluid under accreditation using a flexible scope in molecular virology: setting up the HIV, HBV and HCV Aptima™ Quant Dx assays
  18. Plasma neurofilament light chain is associated with mortality after spontaneous intracerebral hemorrhage
  19. Comparison of the diagnostic performance of two automated urine sediment analyzers with manual phase-contrast microscopy
  20. Development and validation of LC-MS/MS methods to measure tobramycin and lincomycin in plasma, microdialysis fluid and urine: application to a pilot pharmacokinetic research study
  21. Reference Values and Biological Variations
  22. Cord blood S100B: reference ranges and interest for early identification of newborns with brain injury
  23. Hematology and Coagulation
  24. Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
  25. Cancer Diagnostics
  26. Next-generation sequencing for tumor mutation quantification using liquid biopsies
  27. Cardiovascular Diseases
  28. Evolution of the slopes of ST2 and galectin-3 during marathon and ultratrail running compared to a control group
  29. Letters to the Editor
  30. Biological variation of two serum markers for preeclampsia prediction
  31. Daily monitoring of a control material with a concentration near the limit of detection improves the measurement accuracy of highly sensitive troponin assays
  32. Are patients adequately informed about procedures for 24-h urine collection?
  33. Interferences in free thyroxine concentration using the Roche analytical platform: improvement of the third generation?
  34. Procedures for the diagnosis of macro-follicle stimulating hormone (FSH) in a patient with high serum FSH concentrations
  35. False-positive result of immunochromatographic (IC) strip test for the diagnosis of α-thalassemia in samples with autoantibodies
  36. Sample dilution for soluble interleukin-2 receptor α measurement: comparison of two different matrices
  37. The growing problem of predatory publishing: a case report
  38. Cerebrospinal fluid lactate levels according to the site of puncture
Heruntergeladen am 31.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2019-0596/html
Button zum nach oben scrollen